FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

A. Ioan-Facsinay; J.J. de Kimpe; S. Hellwig; P.L. van Lent; F.M.A. Hofhuis; H.H. van Ojik; C. Sedlik; S.A. da Silviera; J. Gerber; Y.F. de Jong; R. Roozendaal; L.A. Aarden; W.B. van der Berg; T. Saito; D. Mosser; S. Amigorena; S. Izui; G.J. van Ommen; M.J. van Vugt; J.G.J. van de Winkel; J.S. Verbeek

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

Translated title of the contribution: FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

A. Ioan-Facsinay, J.J. de Kimpe, S. Hellwig, P.L. van Lent, F.M.A. Hofhuis, H.H. van Ojik, C. Sedlik, S.A. da Silviera, J. Gerber, Y.F. de Jong, R. Roozendaal, L.A. Aarden, W.B. van der Berg, T. Saito, D. Mosser, S. Amigorena, S. Izui, G.J. van Ommen, M.J. van Vugt, J.G.J. van de WinkelJ.S. Verbeek

Center for Translational Immunology (CTI)

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection
Original language	Undefined/Unknown
Pages (from-to)	391-402
Number of pages	12
Journal	Immunity
Volume	16
Issue number	3
Publication status	Published - 2002

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Farmacie(FARM)
Biomedische technologie en medicijnen
Immunology
Pharmacology
Overig medisch onderzoek

Cite this

Ioan-Facsinay, A., de Kimpe, J. J., Hellwig, S., van Lent, P. L., Hofhuis, F. M. A., van Ojik, H. H., Sedlik, C., da Silviera, S. A., Gerber, J., de Jong, Y. F., Roozendaal, R., Aarden, L. A., van der Berg, W. B., Saito, T., Mosser, D., Amigorena, S., Izui, S., van Ommen, G. J., van Vugt, M. J., ... Verbeek, J. S. (2002). FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity, 16(3), 391-402.

@article{ba477ac09eca460da47a689ed8baea66,

title = "FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Farmacie(FARM), Biomedische technologie en medicijnen, Immunology, Pharmacology, Overig medisch onderzoek",

author = "A. Ioan-Facsinay and {de Kimpe}, J.J. and S. Hellwig and {van Lent}, P.L. and F.M.A. Hofhuis and {van Ojik}, H.H. and C. Sedlik and {da Silviera}, S.A. and J. Gerber and {de Jong}, Y.F. and R. Roozendaal and L.A. Aarden and {van der Berg}, W.B. and T. Saito and D. Mosser and S. Amigorena and S. Izui and {van Ommen}, G.J. and {van Vugt}, M.J. and {van de Winkel}, J.G.J. and J.S. Verbeek",

year = "2002",

language = "Undefined/Unknown",

volume = "16",

pages = "391--402",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "3",

}

Ioan-Facsinay, A, de Kimpe, JJ, Hellwig, S, van Lent, PL, Hofhuis, FMA, van Ojik, HH, Sedlik, C, da Silviera, SA, Gerber, J, de Jong, YF, Roozendaal, R, Aarden, LA, van der Berg, WB, Saito, T, Mosser, D, Amigorena, S, Izui, S, van Ommen, GJ, van Vugt, MJ, van de Winkel, JGJ & Verbeek, JS 2002, 'FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection', Immunity, vol. 16, no. 3, pp. 391-402.

TY - JOUR

T1 - FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

AU - Ioan-Facsinay, A.

AU - de Kimpe, J.J.

AU - Hellwig, S.

AU - van Lent, P.L.

AU - Hofhuis, F.M.A.

AU - van Ojik, H.H.

AU - Sedlik, C.

AU - da Silviera, S.A.

AU - Gerber, J.

AU - de Jong, Y.F.

AU - Roozendaal, R.

AU - Aarden, L.A.

AU - van der Berg, W.B.

AU - Saito, T.

AU - Mosser, D.

AU - Amigorena, S.

AU - Izui, S.

AU - van Ommen, G.J.

AU - van Vugt, M.J.

AU - van de Winkel, J.G.J.

AU - Verbeek, J.S.

PY - 2002

Y1 - 2002

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Immunology

KW - Pharmacology

KW - Overig medisch onderzoek

M3 - Article

SN - 1074-7613

VL - 16

SP - 391

EP - 402

JO - Immunity

JF - Immunity

IS - 3

ER -